SOUTH SAN FRANCISCO, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with…
May 10, 2025 10:00 ET | Source: Akero Therapeutics Inc. Analysis of EFX results with AI-based digital pathology underscores the…
Late-breaking oral presentation to include full 12-month clinical data from INSPIRE registrational Phase 3 trial in addition to topline 18-month…
May 08, 2025 07:00 ET | Source: Cullinan Therapeutics, Inc. Company received approval from European Medicines Agency (EMA) for CLN-978;…
May 02, 2025 16:30 ET | Source: Xilio Therapeutics, Inc. WALTHAM, Mass., May 02, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics,…
Court will not hear cross-claim that challenges the PH-ILD indication in the tentatively approved NDA for YUTREPIAFDA can grant final…
April 30, 2025 16:30 ET | Source: LENZ Therapeutics, Inc. SAN DIEGO, April 30, 2025 (GLOBE NEWSWIRE) -- LENZ Therapeutics,…
HOUSTON, April 29, 2025 (GLOBE NEWSWIRE) -- Nuo Therapeutics, Inc. (OTCQB: AURX) (“Nuo”), a commercial stage medical device company pioneering…
Data to be presented in Clinical Trials in Progress Session on Monday, April 28, 2025 April 27, 2025 09:00 ET…
April 26, 2025 10:00 ET | Source: Protara Therapeutics TARA-002 demonstrates 100% complete response rate at any time and 67%…
